Episode

Discussing RA: Advanced therapy outcomes in RA

Podcast
The IMID Forum
Published
Jul 30, 2026
Duration seconds
1646
Processing state
not_requested
Canonical source
https://soundcloud.com/imidforum/discussing-ra-advanced-therapy
Audio
https://feeds.soundcloud.com/stream/2371618295-imidforum-discussing-ra-advanced-therapy.mp3
JSON
/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-advanced-therapy-outcomes-in-ra
Markdown
/podcast/the-imid-forum-981476/discussing-ra-advanced-therapy-outcomes-in-ra.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-ra-advanced-therapy-outcomes-in-ra/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-ra-advanced-therapy-outcomes-in-ra.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Professor Iain McInnes and Doctor Philip Mease for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they examine key findings from studies by Fleischmann et al. and Nozaki et al. discussing the long-term effectiveness and safety of advanced targeted therapies for RA.